Feasibility, Acceptability, and Preliminary Efficacy of an HIV Prevention Intervention for Older Black Women
NCT ID: NCT07181616
Last Updated: 2025-09-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
60 participants
INTERVENTIONAL
2026-05-31
2030-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer are:
Can a revised HIV prevention intervention tailored to reproductive health histories improve HIV knowledge, condom use, and testing in older Black women?
Is the intervention feasible, acceptable, and engaging for participants?
The PI will compare a group of participants receiving the Woman-2-Woman (W2W) intervention to a wait-listed control group to see if the intervention leads to better HIV prevention outcomes.
Participants will:
Join a group-based HIV prevention program designed for older Black women
Be randomly assigned to either:
Start the intervention right away, or
Join a waitlist and start the program 4 weeks later
Take part in four weekly sessions that include group discussions, education, and skill-building activities
Share information about their reproductive health histories and sexual health decisions during focus groups or surveys
Complete questionnaires at the start, after the program ends, and 4 weeks later to assess HIV knowledge, condom use, and testing behavior
This research aims to create a culturally tailored, evidence-based HIV intervention that fits the lives and needs of older Black women and can be used in future, larger studies.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimizing PrEP Utilization Among Alcohol and Other Drug (AOD) Using Women of Color
NCT04018651
HIV Risk and Prevention in Women
NCT02263391
Mobile HIV Prevention App for Black Women
NCT05080972
Increasing PrEP Awareness and Demand Among Black Cisgender Women
NCT05896423
A Reinforcement Intervention for Increasing HIV Testing Among At-Risk Women
NCT03768986
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adapted W2W
HIV intervention focused on aging-related HIV knowledge, identifying HIV prevention practices, and reducing HIV transmission. Intervention given in four, 2 hour educational sessions with a fifth booster session and a final follow up session.
Adapted W2W
HIV education sessions and questionnaires.
Waitlist Control
This group will receive the intervention 8 weeks after the W2W intervention group completes their follow-up and in the same pattern.
Waitlist Control
HIV education sessions and questionnaires given 4 weeks after W2W intervention.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Adapted W2W
HIV education sessions and questionnaires.
Waitlist Control
HIV education sessions and questionnaires given 4 weeks after W2W intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A resident of Selected sites
* A MOCA score of less than 24
* Self-identifying as an African American woman
* English speaking
Exclusion Criteria
* Cognitive impairment
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
Laneshia Conner
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Laneshia Conner
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laneshia Conner, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Kentucky
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Kentucky
Lexington, Kentucky, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
78084
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.